SBT(SH:688392) Sou Hu Cai Jing·2025-10-30 09:32Core Viewpoint - The company, Jiao Cheng Ultrasonic (688392), has shown significant growth in revenue and net profit in the first three quarters of 2025, driven by stable product margins and strong demand in the lithium battery and semiconductor sectors [8]. Financial Performance - In the first three quarters of 2025, the company's main revenue reached 521 million yuan, a year-on-year increase of 27.53% [8]. - The net profit attributable to shareholders was 94.02 million yuan, up 359.81% year-on-year, while the net profit after deducting non-recurring gains and losses was 76.17 million yuan, an increase of 673.31% [8]. - The gross profit margin stood at 65.05% [8]. Business Segments - The company maintains stable gross margins across its product lines, although slight fluctuations occur due to customer product upgrades and changes in product structure [2]. - In the lithium battery sector, the company has established long-term partnerships with key customers, enhancing its competitive edge and market position [3]. - The company is actively expanding its product offerings in the wire harness connector sector, which is increasingly used in electric vehicles and energy storage applications [5]. Product Development - The company has made significant advancements in the semiconductor field, with products like ultrasonic welding machines and advanced ultrasonic scanning microscopes achieving mass production and delivery [6]. - The company is also exploring applications in aerospace and medical fields, leveraging its core ultrasonic technology to meet emerging market demands [7]. Market Outlook - The lithium battery market is expected to continue its growth trajectory, supported by the rapid expansion of the energy storage market and ongoing technological advancements [3]. - The company is optimistic about maintaining its profitability as it enhances its product offerings and increases the proportion of high-margin products in its sales [4]. Institutional Interest - Over the past 90 days, seven institutions have rated the stock, with five giving a "buy" rating and two an "increase" rating, indicating strong institutional interest [8].